Urpo Lamminmäki

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells (2024)

Biomedicine and Pharmacotherapy

Saha, Nayanendu; Lee, Sang Gyu; Brockmann, Eeva-Christine; de la Cruz, M. Jason; Goldgur, Yehuda; Mendoza, Rachelle P.; Stanchina, Elisa de; Love, Tanzy M.; Marvald, Josh; Xu, Yan; Xu, Kai; Himanen, Juha P.; Lamminmäki, Urpo; Veach, Darren; Nikolov, Dimitar B.

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Increased stable integration efficiency in CHO cells through enhanced nuclear localization of Bxb1 serine integrase (2024)

BMC Biotechnology

Huhtinen, Olli; Prince, Stuart; Lamminmäki, Urpo; Salbo, Rune; Kulmala, Antti

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Tetraspanin immunoassay for the detection of extracellular vesicles and renal cell carcinoma (2024)

Nano select

Khan Misba, Islam Md. Khirul, Rahman Mafiur, Dhondt Bert, Quintero Ileana, Puhka Maija, Jaakkola Panu M., Lamminmäki Urpo, Leivo Janne

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)

Congress of the European Committee for Treatment and Research in Multiple Sclerosis, Multiple Sclerosis

Ahola, Venla; Saraste, Maija; Matilainen, Markus; Brockmann, Eeva-Christine; Lamminmaki, Urpo; Airas, Laura

(Konferenssiposteri)

Controlled labelling of tracer antibodies for time-resolved fluorescence-based immunoassays (2024)

Scientific Reports

Kushnarova-Vakal, Anastasiia; Aalto, Rami; Huovinen, Tuomas; Wittfooth, Saara; Lamminmäki, Urpo

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis (2024)

Journal of Biological Chemistry

Leimu, Laura; Holm, Patrik; Gąciarz, Anna; Haavisto, Oskar; Prince, Stuart; Pesonen, Ullamari; Huovinen, Tuomas; Lamminmäki, Urpo

(A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä )

RECOMBINANT ANTIBODIES AGAINST ANATOXIN: A CYANOBACTERIAL NEUROTOXIN (2023)

WorldLab - EuroMedLab, Clinical Chemistry and Laboratory Medicine

Akter Sultana, Rosenberg Jaana, Lamminmäki Urpo

(O2 Muu julkaisu )

Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects (2023)

Scientific Reports

Oksanen Sami, Saarinen Roope, Korkiakoski Anttoni, Lamminmäki Urpo, Huovinen Tuomas

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform (2023)

Frontiers in Bioengineering and Biotechnology

Huhtinen Olli, Salbo Rune, Lamminmäki Urpo, Prince Stuart

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles (2023)

Biomarker research

Islam Md Khirul, Khan Misba, Gidwani Kamlesh, Witwer W Witwer, Lamminmäki Urpo, Leivo Janne

(Vertaisarvioitu katsausartikkeli tieteellisessä aikakauslehdessä (A2))

Ota yhteyttä

Asiantuntijuusalueet

Opetus

Tutkimus

Julkaisut

Järjestä:

Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells (2024)

Increased stable integration efficiency in CHO cells through enhanced nuclear localization of Bxb1 serine integrase (2024)

Tetraspanin immunoassay for the detection of extracellular vesicles and renal cell carcinoma (2024)

Plasma CHI3L1 associates with increased TSPO-PET measurable microglial activation in patients with progressive multiple sclerosis (2024)

Controlled labelling of tracer antibodies for time-resolved fluorescence-based immunoassays (2024)

Epitope-specific antibody fragments block aggregation of AGelD187N, an aberrant peptide in gelsolin amyloidosis (2024)

RECOMBINANT ANTIBODIES AGAINST ANATOXIN: A CYANOBACTERIAL NEUROTOXIN (2023)

Genotyped functional screening of soluble Fab clones enables in-depth analysis of mutation effects (2023)

Selection of biophysically favorable antibody variants using a modified Flp-In CHO mammalian display platform (2023)

Lectins as potential tools for cancer biomarker discovery from extracellular vesicles (2023)